Butonitazene is an analgesic drug related to etonitazene, which was first reported in 1957,and has been shown to have approximately 50 times the potency of morphine by central routes of administration, but if used orally it has been shown to have approximately 6 times the potency of morphine.
The Butonitazene effects are similar to other opioids like such Fent, Isotonitazene and similar products. The effect including analgesia, euphoria, sleepiness. Adverse effects include vomiting, and respiratory depression that can potentially be fatal. Because of high dependency potential and dangerous adverse effects it has never been introduced in pharmacotherapy.
This product is intended for research and forensic applications.